7Baggers
 Director Makes Bold Move with Major Immuneering Stock Purchase  TipRanks Thu, 02 Oct 2025 02:05:07 GMT
 Feinberg Peter buys Immuneering Corp (IMRX) shares for $52,730  Investing.com Wed, 01 Oct 2025 13:13:00 GMT
 Director’s Bold Move: Major Investment in Immuneering Stock!  TipRanks Wed, 01 Oct 2025 02:22:13 GMT
 Immuneering (IMRX) Price Target Increased by 29.69% to 16.93  Nasdaq Tue, 30 Sep 2025 20:49:00 GMT
 Immuneering (NASDAQ:IMRX) Given "Buy" Rating at HC Wainwright  MarketBeat Tue, 30 Sep 2025 12:20:03 GMT
 transcript : immuneering corporation - special call  MarketScreener Mon, 29 Sep 2025 18:05:37 GMT
 immuneering corporation shares drop 13%, impacting investor confidence  Berawang News Sat, 27 Sep 2025 14:05:22 GMT
 can immuneering (nasdaq:imrx) afford to invest in growth?  富途牛牛 Sat, 27 Sep 2025 05:25:35 GMT
 Immuneering to host call on pancreatic cancer treatment data By Investing.com  Investing.com Nigeria Sat, 27 Sep 2025 03:28:25 GMT
 Immuneering to host call on pancreatic cancer treatment data  Investing.com Fri, 26 Sep 2025 20:24:56 GMT
 Immuneering Announces Public Offering to Raise $164.1M  TipRanks Thu, 25 Sep 2025 21:50:28 GMT
 To vanquish pancreatic at last? Immuneering scores in phase II  BioWorld MedTech Thu, 25 Sep 2025 20:38:42 GMT
 imrx: oppenheimer raises target price amidst outperform rating |  GuruFocus Thu, 25 Sep 2025 14:37:28 GMT
 Immuneering Corporation’s Stock Rollercoaster: What’s Next?  StocksToTrade Thu, 25 Sep 2025 14:03:00 GMT
 immuneering price target raised to $30 from $21 at oppenheimer  TipRanks Thu, 25 Sep 2025 13:36:52 GMT
 immuneering corporation (imrx) pt raised to $30 at oppenheimer  StreetInsider Thu, 25 Sep 2025 13:23:50 GMT
 biggest stock movers thursday: rig, imrx, and more  MSN Thu, 25 Sep 2025 09:22:05 GMT
 Immuneering Announces $25M Securities Purchase Agreement  TipRanks Thu, 25 Sep 2025 08:53:04 GMT
 immuneering prices $175 million stock offering  MarketScreener Thu, 25 Sep 2025 08:05:19 GMT
 Immuneering prices $175 million public offering at $9.23 per share  Investing.com Thu, 25 Sep 2025 04:26:27 GMT
 why immuneering stock soared over 40% after-hours today  Stocktwits Thu, 25 Sep 2025 02:04:47 GMT
 Immuneering reports strong survival data in pancreatic cancer trial  Investing.com Wed, 24 Sep 2025 21:15:24 GMT
 Immuneering Announces Proposed Underwritten Public Offering  GlobeNewswire Wed, 24 Sep 2025 20:05:00 GMT
 Immuneering reports 86% survival rate in pancreatic cancer trial  StreetInsider Wed, 24 Sep 2025 20:01:55 GMT
 Mizuho Securities Keeps Their Buy Rating on Immuneering (IMRX)  The Globe and Mail Wed, 24 Sep 2025 16:46:00 GMT
 Immuneering Announces Extraordinary 86% Overall Survival at  GlobeNewswire Wed, 24 Sep 2025 07:00:00 GMT
 immuneering announces public offering to raise $164.1m  MSN Wed, 24 Sep 2025 07:00:00 GMT
 immuneering files $300m mixed securities shelf  MSN Sun, 21 Sep 2025 03:47:07 GMT
 Immuneering Appoints Dr. Thomas Schall as Chairman of the Board  GlobeNewswire Tue, 16 Sep 2025 07:00:00 GMT
 immuneering appoints schall as chairman of the board  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 a slow and steady approach to pancreatic cancer therapy  the-scientist.com Tue, 16 Sep 2025 02:26:15 GMT
 immuneering corporation (imrx) pt raised to $11 at needham  StreetInsider Mon, 15 Sep 2025 11:26:50 GMT
 A Slow and Steady Approach to Pancreatic Cancer Therapy  the-scientist.com Mon, 15 Sep 2025 07:00:00 GMT
 Needham raises Immuneering stock price target to $11 on PDAC study  Investing.com Mon, 15 Sep 2025 07:00:00 GMT
 wall street analysts are bullish on top healthcare picks  The Globe and Mail Fri, 12 Sep 2025 16:30:00 GMT
 immuneering to present updated pancreatic cancer survival data by investing.com  Investing.com Australia Thu, 11 Sep 2025 07:46:08 GMT
 oppenheimer reiterates outperform rating on immuneering stock ahead of data  Investing.com India Thu, 11 Sep 2025 00:53:11 GMT
 immuneering to present updated pancreatic cancer survival data  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 published on: 2025-09-08 20:03:39  beatles.ru Mon, 08 Sep 2025 17:04:15 GMT
 published on: 2025-09-08 19:59:00  beatles.ru Mon, 08 Sep 2025 17:00:30 GMT
 pleasing signs as a number of insiders buy immuneering stock  Yahoo Finance Fri, 05 Sep 2025 07:00:00 GMT
 published on: 2025-08-31 19:42:17  Newser Mon, 01 Sep 2025 00:42:17 GMT
 published on: 2025-08-29 15:30:36  Newser Fri, 29 Aug 2025 20:30:36 GMT
 published on: 2025-08-29 01:23:33  Newser Fri, 29 Aug 2025 06:23:33 GMT
 published on: 2025-08-29 00:05:44  Newser Fri, 29 Aug 2025 05:05:44 GMT
 published on: 2025-08-28 12:45:47  Newser Thu, 28 Aug 2025 17:45:47 GMT
 published on: 2025-08-27 15:23:21  Newser Wed, 27 Aug 2025 20:23:21 GMT
 published on: 2025-08-27 14:39:10  Newser Wed, 27 Aug 2025 19:39:10 GMT
 published on: 2025-08-27 13:49:51  Newser Wed, 27 Aug 2025 18:49:51 GMT
 published on: 2025-08-27 06:48:41  Newser Wed, 27 Aug 2025 11:48:41 GMT

Immuneering Corporation
(NASDAQ:IMRX) 

IMRX stock logo

Immuneering Corporation provides genetic, genomic, and proteomic data analysis services for pharmaceutical companies to generate biological insights that enhance the clinical and commercial success of medicines. The company was incorporated in 2008 and is based in Cambridge, Massachusetts.

Founded: 2008
CEO / Co-Founder: Ben Zeskind 
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends